Výsledky vyhledávání - "H F, Weisman"

Increased Risk of Non-Q Wave Myocardial Infarction After Directional Atherectomy Is Platelet Dependent: Evidence From the EPIC Trial

Autor: James C. Blankenship, Keaven M. Anderson, Eric J. Topol, Seth J. Worley, Robert M. Califf, Jeffrey Lefkovits, H F Weisman, G L Stoner, J D Talley

Publikováno v: Journal of the American College of Cardiology. 28:849-855

Objectives. We sought to determine the effects of platelet glycoprotein IIb/IIIa receptor blockade on adverse outcomes, especially non-Q wave myocardial infarction, in patients undergoing directional atherectomy in the Evaluation of c7E3 for the Prev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c38a12db372d75dae1f59d29ace429ec
https://doi.org/10.1016/s0735-1097(96)00239-2

Zobrazit plný text záznamu

A method to reconstruct myocardial sarcomere lengths and orientations at transmural sites in beating canine hearts

Autor: H. F. Weisman, M. J. Royce, Edward K. Rodriguez, Michelle K. Leppo, A.S. Douglas, William C. Hunter

Publikováno v: American Journal of Physiology-Heart and Circulatory Physiology. 263:H293-H306

The ability to measure cyclic changes in myocardial sarcomere lengths and orientations during cardiac ejection and filling would improve our understanding of how the cellular processes of contraction relate to the pumping of the whole heart. Previous

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b1ac31c18ff01c1f13c92e04758b911
https://doi.org/10.1152/ajpheart.1992.263.1.h293

Zobrazit plný text záznamu

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade

Autor: A M, Lincoff, J E, Tcheng, R M, Califf, D J, Kereiakes, T A, Kelly, G C, Timmis, N S, Kleiman, J E, Booth, C, Balog, C F, Cabot, K M, Anderson, H F, Weisman, E J, Topol

Publikováno v: Circulation. 99(15)

Blockade of the platelet glycoprotein IIb/IIIa receptor with the monoclonal antibody fragment abciximab was shown in a placebo-controlled randomized trial to reduce the incidence of acute ischemic complications within 30 days among a broad spectrum o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b426a013785bedced1f89df749792d4c
https://pubmed.ncbi.nlm.nih.gov/10208997

Zobrazit plný text záznamu

Current Antiplatelet Therapy

Autor: H. F. Weisman, R. E. Jordan, J. A. Jakubowski

Publikováno v: Antithrombotics ISBN: 9783642641909

Initially considered circulating cell fragments, the blood platelet is now recognized to play vital roles in both hemostasis and thrombosis. Recognition of its role in arterial thrombosis has, in part, been driven by the study of the effects of plate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4854e07397a09fd9104f7e9fd04994a8
https://doi.org/10.1007/978-3-642-59942-2_7

Zobrazit plný text záznamu

Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators

Autor: N S, Kleiman, A M, Lincoff, D J, Kereiakes, D P, Miller, F V, Aguirre, K M, Anderson, H F, Weisman, R M, Califf, E J, Topol

Publikováno v: Circulation. 97(19)

After angioplasty, major complications and ischemic events occur more frequently in diabetic than nondiabetic patients. To determine whether treatment with abciximab is effective in reducing these events in diabetics, we analyzed characteristics and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a140ddd2d2f507b6b5ec5c19819ec280
https://pubmed.ncbi.nlm.nih.gov/9609084

Zobrazit plný text záznamu

Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators

Autor: D J, Kereiakes, A M, Lincoff, D P, Miller, J E, Tcheng, C F, Cabot, K M, Anderson, H F, Weisman, R M, Califf, E J, Topol

Publikováno v: Circulation. 97(9)

The clinical and angiographic demographics of patients requiring unplanned coronary stent deployment and the optimal adjunct pharmacotherapy in this population are not well described. This report details the EPILOG trial experience with unplanned cor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::17380c6caec8b76b93ee941362b32ed9
https://pubmed.ncbi.nlm.nih.gov/9521334

Zobrazit plný text záznamu

Evidence for prevention of death and myocardial infarction with platelet membrane glycoprotein IIb/IIIa receptor blockade by abciximab (c7E3 Fab) among patients with unstable angina undergoing percutaneous coronary revascularization. EPIC Investigators. Evaluation of 7E3 in Preventing Ischemic Complications

Autor: A M, Lincoff, R M, Califf, K M, Anderson, H F, Weisman, F V, Aguirre, N S, Kleiman, R A, Harrington, E J, Topol

Publikováno v: Journal of the American College of Cardiology. 30(1)

We sought to evaluate whether patients with unstable angina undergoing coronary intervention derive particular clinical benefit from potent platelet inhibition.Plaque rupture and platelet aggregation are pathogenetic processes common to unstable angi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::22bd08064bb370d655ac5eed70024150
https://pubmed.ncbi.nlm.nih.gov/9207636

Zobrazit plný text záznamu

Increased risk of non-Q wave myocardial infarction after directional atherectomy is platelet dependent: evidence from the EPIC trial. Evaluation of c7E3 for the Prevention of Ischemic Complications

Autor: J, Lefkovits, J C, Blankenship, K M, Anderson, G L, Stoner, J D, Talley, S J, Worley, H F, Weisman, R M, Califf, E J, Topol

Publikováno v: Journal of the American College of Cardiology. 28(4)

We sought to determine the effects of platelet glycoprotein IIb/IIIa receptor blockade on adverse outcomes, especially non-Q wave myocardial infarction, in patients undergoing directional atherectomy in the Evaluation of c7E3 for the Prevention of Is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7c8c5898db274b0edd0d5a9f0f7d2b77
https://pubmed.ncbi.nlm.nih.gov/8837559

Zobrazit plný text záznamu

Anti-platelet monoclonal antibodies for the prevention of arterial thrombosis: experience with ReoPro, a monoclonal antibody directed against the platelet GPIIb/IIIa receptor

Autor: K. M. Anderson, H. F. Weisman, Catherine F. Cabot, T. F. Schaible, R. E. Jordan

Publikováno v: Biochemical Society transactions. 23(4)

Platelets are implicated in a variety of serious vaso-occlusive and thromboembolic disorders that together constitute one of the most common causes of death throughout the world. Platelet aggregation and subsequent thrombosis at the site of an injure

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d838c0b0bfc9923ee4c4efcef4d395e
https://pubmed.ncbi.nlm.nih.gov/8654680

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání